Denmark logged 3 verified funding rounds in the week ending 01 Oct 2023, totalling ≈$55.8M. Acesion Pharma anchors the week with a ≈$47.0M Series B in Manufacturing.
| Country | Denmark |
| Deals this week | 3 |
| Total raised | ≈$55.8M |
| Top sector | Manufacturing (1) |
| Most common round | Seed (1) |
| Sources tracked | 13 |
| # | Company | Amount | Round | Sector | Announced |
|---|---|---|---|---|---|
| 1 | Acesion Pharma | $47.0M | Series B | Manufacturing | 26 Sept 2023 |
| 2 | Omada | $7.5M | Seed | Technology, Information and Media | 27 Sept 2023 |
| 3 | LastObject | $1.3M | Series A | Retail | 29 Sept 2023 |
Acesion Pharma$47.0M · Series B · Manufacturing · Denmark
Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
3 more sources tracked. Read the full press release and reporter coverage.
Sign up to read →
Omada$7.5M · Seed · Technology, Information and Media · Denmark
Omada, a global market leader in Identity Governance and Administration (IGA), offers a full-featured, enterprise-grade, cloud-native IGA solution that enables organizations to achieve compliance, reduce risk, and maximi
6 more sources tracked. Read the full press release and reporter coverage.
Sign up to read →Manufacturing accounted for 1 of 3 verified deals in Denmark this week. The stage mix was 1 early-stage (pre-seed to seed) against 2 Series A or later.
$1.3M · Series A · Retail · Denmark
We are a small dedicated team with a mission to end the need for single use items. Single use items are the main source of marine pollution and costs the earth huge amounts of CO2 and resources every day.
1 more source tracked. Read the full press release and reporter coverage.
Sign up to read →
